- Report
- March 2024
- 196 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- May 2024
- 192 Pages
Global
From €5178EUR$5,450USD£4,454GBP
- Report
- January 2024
- 200 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- December 2023
- 190 Pages
Global
€4745EUR$4,995USD£4,082GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1900EUR$2,000USD£1,634GBP
- Report
- March 2024
- 295 Pages
Global
From €3987EUR$4,197USD£3,430GBP
- Report
- March 2024
- 186 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- February 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- January 2024
- 200 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1900EUR$2,000USD£1,634GBP
- Report
- February 2024
- 110 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 118 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- January 2024
- 200 Pages
Global
From €3943EUR$4,150USD£3,392GBP
- Report
- January 2020
- 508 Pages
Global
From €4654EUR$4,899USD£4,004GBP
- Clinical Trials
- July 2019
- 170 Pages
Global
From €2423EUR$2,550USD£2,084GBP
€2850EUR$3,000USD£2,452GBP
- Report
- February 2018
- 80 Pages
Global
From €5653EUR$5,950USD£4,863GBP
- Report
- January 2023
- 159 Pages
Global
From €2375EUR$2,500USD£2,043GBP
- Report
- January 2022
- 60 Pages
Global
From €3753EUR$3,950USD£3,228GBP
- Report
- January 2022
- 115 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- August 2020
- 85 Pages
North America
From €4513EUR$4,750USD£3,882GBP
![Loading Indicator](//www.researchandmarkets.com/images/loading.gif)
The Bone Marrow Transplant (BMT) market is a subset of the stem cell market. BMT is a medical procedure in which healthy stem cells are transplanted into a patient to replace damaged or diseased cells. The stem cells used in BMT are typically harvested from the patient's own bone marrow, or from a donor. BMT is used to treat a variety of conditions, including leukemia, lymphoma, and aplastic anemia.
The BMT market is highly competitive, with a number of companies offering products and services related to the procedure. These include companies that provide stem cell collection and processing services, as well as those that manufacture and distribute BMT-related products, such as cell culture media and reagents. Additionally, there are companies that specialize in providing BMT-related services, such as patient education and support.
Some of the major companies in the BMT market include StemCyte, LifeCell, and Osiris Therapeutics. Other notable companies include BioLife Solutions, Cellectis, and Thermo Fisher Scientific. Show Less Read more